Mark N. Tompkins 13D and 13G filings for Augmedix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:38 pm Sale | 2022-12-31 | 13G | Augmedix, Inc. AUGX | Mark N. Tompkins | 914,229 2.400% | -1,020,891 (-52.76%) | Filing |
| 2022-02-14 4:42 pm Purchase | 2021-12-31 | 13G | Augmedix, Inc. AUGX | Mark N. Tompkins | 1,935,120 5.200% | 1,935,120 (New Position) | Filing |